Diamedica Therapeutics Inc. · NASDAQ:DMAC
Pauls Dietrich John received 60,200 Diamedica Therapeutics Inc. shares as an award (Form 4)
Traded Aug 10, 2026 · Filed Aug 12, 2026
On Aug 10, 2026, Pauls Dietrich John (Director, President & CEO) received 60,200 Diamedica Therapeutics Inc. shares as an award, leaving 128,791 shares. Filed Aug 12, 2026 (Form 4).
- Awarded
- 60,200 shares
- Holding after
- 128,791 shares
- Trading plan
- No
- Role
- Director, President & CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 10, 2026 | Voting Common Shares, no par value per share | Award | 60,200 | 128,791 | Direct |
Source
Related
- Diamedica Therapeutics Inc.
- Pauls Dietrich John
- Diamedica Therapeutics Inc. shareholders
- Schedule 13G/A · John Fichthorn · Feb 17, 2026
- Schedule 13G/A · Cooperman Leon G · Feb 17, 2026
- Schedule 13G/A · Trill AB · Feb 6, 2026
- Schedule 13G/A · Richard Jacinto II · Nov 7, 2025
- Schedule 13G/A · Cooperman Leon G · Oct 15, 2025